Franklin Resources
ARTV

Franklin Resources’s Artiva Biotherapeutics ARTV Stock Holding History

Franklin Resources’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.35M Hold
520,327
– – ﹤0.01% 1705
2025
Q4 		$2.23M Hold
520,327
– – ﹤0.01% 1730
2025
Q3 		$1.49M Hold
520,327
– – ﹤0.01% 1902
2025
Q2 		$786K Hold
520,327
– – ﹤0.01% 2105
2025
Q1 		$1.56M Buy
520,327
+26
+0% +$140 ﹤0.01% 1789
2024
Q4 		$5.24M Hold
520,301
– – ﹤0.01% 1329
2024
Q3 		$7.44M Buy
+520,301
New +$6.03M ﹤0.01% 1219

Other funds holding ARTV

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources's ARTV Position: Q1 2026 in Review

Franklin Resources held its Artiva Biotherapeutics (ARTV) position steady in Q1 2026 at 520,327 shares worth $3.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

Franklin Resources first reported a position in ARTV in Q3 2024 and has held it in 7 quarters since. The position peaked at $7.44M in Q3 2024. 40 funds tracked by Wall St. Rank hold ARTV as of Q1 2026.

  • Franklin Resources held 520,327 shares of Artiva Biotherapeutics worth $3.35M as of Q1 2026.
  • Franklin Resources left its Artiva Biotherapeutics share count unchanged in Q1 2026.
  • Artiva Biotherapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1705 holding.
  • Franklin Resources first reported a position in Artiva Biotherapeutics in Q3 2024 and has held it in 7 quarters since.
  • Franklin Resources's Artiva Biotherapeutics position peaked at $7.44M in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.